156 related articles for article (PubMed ID: 11934966)
1. Characteristics and outcome of 49 patients with symptomatic cryoglobulinaemia.
Rieu V; Cohen P; André MH; Mouthon L; Godmer P; Jarrousse B; Lhote F; Ferrière F; Dény P; Buchet P; Guillevin L
Rheumatology (Oxford); 2002 Mar; 41(3):290-300. PubMed ID: 11934966
[TBL] [Abstract][Full Text] [Related]
2. Cryoglobulinemia and cutaneous leukocytoclastic vasculitis with hepatitis C virus infection.
Buezo GF; García-Buey M; Rios-Buceta L; Borque MJ; Aragües M; Daudén E
Int J Dermatol; 1996 Feb; 35(2):112-5. PubMed ID: 8850039
[TBL] [Abstract][Full Text] [Related]
3. Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis C virus infection?
Apartis E; Léger JM; Musset L; Gugenheim M; Cacoub P; Lyon-Caen O; Pierrot-Deseilligny C; Hauw JJ; Bouche P
J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):661-6. PubMed ID: 8648334
[TBL] [Abstract][Full Text] [Related]
4. Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection.
Wong VS; Egner W; Elsey T; Brown D; Alexander GJ
Clin Exp Immunol; 1996 Apr; 104(1):25-31. PubMed ID: 8603528
[TBL] [Abstract][Full Text] [Related]
5. Mixed cryoglobulinaemia in patients with chronic hepatitis C infection: prevalence, significance and relationship with different viral genotypes.
Horcajada JP; García-Bengoechea M; Cilla G; Etxaniz P; Cuadrado E; Arenas JI
Ann Med; 1999 Oct; 31(5):352-8. PubMed ID: 10574508
[TBL] [Abstract][Full Text] [Related]
6. Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus.
Cresta P; Musset L; Cacoub P; Frangeul L; Vitour D; Poynard T; Opolon P; Nguyen DT; Golliot F; Piette JC; Huraux JM; Lunel F
Gut; 1999 Jul; 45(1):122-8. PubMed ID: 10369715
[TBL] [Abstract][Full Text] [Related]
7. [Serum CXCL-10 level in chronic hepatitis C patients with cryoglobulinemia and its influence on antiviral therapy].
Fan XH; Deng ZH; Xu XY
Zhonghua Gan Zang Bing Za Zhi; 2016 Oct; 24(10):744-748. PubMed ID: 27938559
[No Abstract] [Full Text] [Related]
8. Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinaemia.
Donada C; Crucitti A; Donadon V; Tommasi L; Zanette G; Crovatto M; Santini GF; Chemello L; Alberti A
J Viral Hepat; 1998 May; 5(3):179-85. PubMed ID: 9658371
[TBL] [Abstract][Full Text] [Related]
9. Mixed cryoglobulinaemia and chronic hepatitis C virus infection: the rheumatic manifestations.
Leone N; Pellicano R; Ariata Maiocco I; Modena V; Marietti G; Rizzetto M; Ponzetto A
J Med Virol; 2002 Feb; 66(2):200-3. PubMed ID: 11782928
[TBL] [Abstract][Full Text] [Related]
10. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
11. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
[TBL] [Abstract][Full Text] [Related]
12. [The effect of cryoglobulinemia on the antiviral therapy in patients with chronic hepatitis C].
Fan XH; Wang LF; Liu LC; Yao Y; Shan Y; Lu HY; Wu CH; Xu XY; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):721-5. PubMed ID: 22409840
[TBL] [Abstract][Full Text] [Related]
13. Quantitative measurement of hepatitis C virus core antigen is affected by the presence of cryoglobulins.
Pham BN; Martinot-Peignoux M; Ripault MP; Boyer N; Levy V; Marcellin P
Clin Exp Immunol; 2006 Nov; 146(2):211-7. PubMed ID: 17034572
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function.
Lapinski TW; Parfieniuk A; Rogalska-Plonska M; Czajkowska J; Flisiak R
Liver Int; 2009 Sep; 29(8):1158-61. PubMed ID: 19602133
[TBL] [Abstract][Full Text] [Related]
15. Longterm efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection.
Naarendorp M; Kallemuchikkal U; Nuovo GJ; Gorevic PD
J Rheumatol; 2001 Nov; 28(11):2466-73. PubMed ID: 11708420
[TBL] [Abstract][Full Text] [Related]
16. Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study.
Gragnani L; Fabbrizzi A; Triboli E; Urraro T; Boldrini B; Fognani E; Piluso A; Caini P; Ranieri J; Monti M; Laffi G; Zignego AL
Dig Liver Dis; 2014 Sep; 46(9):833-7. PubMed ID: 24953206
[TBL] [Abstract][Full Text] [Related]
17. Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus.
Saadoun D; Aaron L; Resche-Rigon M; Pialoux G; Piette JC; Cacoub P;
AIDS; 2006 Apr; 20(6):871-7. PubMed ID: 16549971
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis G and hepatitis C RNA viruses coexisting in cryoglobulinemia.
Tepper JL; Feinman SV; D'Costa L; Sooknannan R; Pruzanski W
J Rheumatol; 1998 May; 25(5):925-8. PubMed ID: 9598893
[TBL] [Abstract][Full Text] [Related]
19. Cryoglobulinemia with vasculitis associated with hepatitis C virus infection.
Marcellin P; Descamps V; Martinot-Peignoux M; Larzul D; Xu L; Boyer N; Pham BN; Crickx B; Guillevin L; Belaich S
Gastroenterology; 1993 Jan; 104(1):272-7. PubMed ID: 8380394
[TBL] [Abstract][Full Text] [Related]
20. Anti-C1q in chronic hepatitis C virus genotype IV infection: association with autoimmune rheumatologic manifestations.
Fadda SH; Bassyouni IH; Hamdy A; Foad NA; Wali IE
Immunol Invest; 2015; 44(1):45-55. PubMed ID: 25028787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
